Raj Som Pruthi - 29 Jan 2025 Form 4 Insider Report for enGene Holdings Inc. (ENGN)

Role
Chief Medical Officer
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
Issuer symbol
ENGN
Transactions as of
29 Jan 2025
Net transactions value
$0
Form type
4
Filing time
31 Jan 2025, 16:46:11 UTC
Previous filing
25 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENGN Stock Option (Right to Buy) Award $0 +280,000 $0.000000 280,000 29 Jan 2025 Common Shares 280,000 $7.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests monthly in substantially equal amounts for 48 months, subject to the reporting person's continued service.